Obesity Drug Update: The Lost Decade?
The growing worldwide obesity epidemic and obesity-related disorders present a huge unmet medical need for safe and effective anti-obesity medications. The discovery of leptin in 1994 was rapidly succeeded by a wave of related discoveries leading to the elaboration of a hypothalamic melanocortinergi...
Main Authors: | Fayi Yao, Robert George MacKenzie |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-11-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | http://www.mdpi.com/1424-8247/3/12/3494/ |
Similar Items
-
Are anti-inflammatory drugs an appropriate option for treating obesity?
by: Andreucci, Amy Jada
Published: (2016) -
To evaluate efficacy and safety of Caralluma fimbriata in overweight and obese patients: A randomized, single blinded, placebo control trial
by: Ekta Arora, et al.
Published: (2015-01-01) -
The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg
by: Marcio C. Mancini, et al.
Published: (2017-05-01) -
Anti-Obesity Drugs: A Review about Their Effects and Safety
by: Jun Goo Kang, et al.
Published: (2012-02-01) -
Paradoxical Effects of Fruit on Obesity
by: Satya P. Sharma, et al.
Published: (2016-10-01)